{
    "id": 29339,
    "fullName": "ABL1 Y440C",
    "impact": "missense",
    "proteinEffect": "unknown",
    "geneVariantDescriptions": [
        {
            "description": "ABL1 Y440C lies within the protein kinase domain of the Abl1 protein (UniProt.org). Y440C has been identified in the scientific literature (PMID: 30584318), but has not been biochemically characterized and therefore, its effect on Abl1 protein function is unknown (PubMed, Oct 2019).",
            "references": [
                {
                    "id": 14104,
                    "pubMedId": 30584318,
                    "title": "A novel BCR-ABL1 mutation in a patient with Philadelphia chromosome-positive B-cell acute lymphoblastic leukemia.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/30584318"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 25,
        "geneSymbol": "ABL1",
        "terms": [
            "ABL1",
            "ABL",
            "BCR-ABL",
            "bcr/abl",
            "c-ABL",
            "c-ABL1",
            "CHDSKM",
            "JTK7",
            "p150",
            "v-abl"
        ]
    },
    "variant": "Y440C",
    "createDate": "02/13/2019",
    "updateDate": "10/01/2019",
    "referenceTranscriptCoordinates": {
        "id": 178655,
        "transcript": "NM_005157",
        "gDna": "chr9:g.130878463A>G",
        "cDna": "c.1319A>G",
        "protein": "p.Y440C",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 15970,
            "approvalStatus": "Case Reports/Case Series",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a clinical case study, an adult patient with Philadelphia chromosome (BCR-ABL1) positive B-cell acute lymphoblastic leukemia was found to have acquired an ABL1 Y440C mutation upon disease recurrence following Sprycel (dasatinib) therapy (PMID: 30584318).",
            "molecularProfile": {
                "id": 31347,
                "profileName": "BCR - ABL1 ABL1 Y440C"
            },
            "therapy": {
                "id": 717,
                "therapyName": "Dasatinib",
                "synonyms": null
            },
            "indication": {
                "id": 60592,
                "name": "B-cell adult acute lymphocytic leukemia",
                "source": "DOID"
            },
            "responseType": "predicted - resistant",
            "references": [
                {
                    "id": 14104,
                    "pubMedId": 30584318,
                    "title": "A novel BCR-ABL1 mutation in a patient with Philadelphia chromosome-positive B-cell acute lymphoblastic leukemia.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/30584318"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 15969,
            "approvalStatus": "Case Reports/Case Series",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a clinical case study, Bosulif (bosutinib) resulted in decreased levels of BCR-ABL1 transcript after 7 weeks of treatment in an adult patient with Philadelphia chromosome (BCR-ABL1)-positive B-cell acute lymphoblastic leukemia harboring ABL1 Y440C, however, minimal residual disease remained (PMID: 30584318).",
            "molecularProfile": {
                "id": 31347,
                "profileName": "BCR - ABL1 ABL1 Y440C"
            },
            "therapy": {
                "id": 690,
                "therapyName": "Bosutinib",
                "synonyms": null
            },
            "indication": {
                "id": 60592,
                "name": "B-cell adult acute lymphocytic leukemia",
                "source": "DOID"
            },
            "responseType": "predicted - sensitive",
            "references": [
                {
                    "id": 14104,
                    "pubMedId": 30584318,
                    "title": "A novel BCR-ABL1 mutation in a patient with Philadelphia chromosome-positive B-cell acute lymphoblastic leukemia.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/30584318"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 31347,
            "profileName": "BCR - ABL1 ABL1 Y440C",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 178655,
            "transcript": "NM_005157",
            "gDna": "chr9:g.130878463A>G",
            "cDna": "c.1319A>G",
            "protein": "p.Y440C",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}